An observational study in Thalassemia Alpha and Hemolytic Anemia, sponsored by HaEmek Medical Center, Israel. Completed at 1 site in Israel. Open to participants aged Up to 20 Years. Per ClinicalTrials.gov, last updated 2015-09-01.
Sponsored by HaEmek Medical Center, Israel · Observational
The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.
Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized.
416 studies on the registry are indexed under Thalassemia; 67 are open to participants now.
This study's enrollment of 50 is below the median of 100 across 120 observational studies indexed under Thalassemia.
Browse Thalassemia studies →HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A group of 50 children that underwent workup due to hemolytic anemia and were further diagnosis as suffering from clinical alpha thalassemia.
Exclusion Criteria:
Patients diagnosed with alpha thalassemia mutations and anemia
Other: Medical records summary
Summary of Medical files and laboratory results.
Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia
Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia
Time frame: One year
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HaEmek Medical Center, Israel